Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve repair and cardiac revascularization. The approval enables minimally invasive ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

Intuitive Surgical’s fourth quarter saw results above Wall Street’s expectations, driven by increased global procedure volumes and demand for the new da Vinci 5 system. Management highlighted ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Medtronic's Hugo robotic surgery system has been approved in the U.S. for urologic procedures. The company is also a leader in cardiac devices, ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and ...